SARS-CoV-2 Omicron Variant Wave in India: Advent, Phylogeny and Evolution
Singh, U. B.; Deb, S.; Chaudhry, R.; Bala, K.; Rani, L.; Gupta, R.; Kumari, L.; Ahmed, J.; Gaurav, S.; Perumalla, S.; Nizam, M.; Mishra, A.; Stephenraj, J.; Shukla, J.; Bhardwaj, D.; Nayer, J.; Aggarwal, P.; Kabra, M.; Ahuja, V.; Sinha, S.; Guleria, R.
Show abstract
SARS-CoV-2 evolution has continued to generate variants, responsible for new pandemic waves locally and globally. Varying disease presentation and severity has been ascribed to inherent variant characteristics and vaccine immunity. This study analyzed genomic data from 305 whole genome sequences from SARS-CoV-2 patients before and through the third wave in India. Delta variant was responsible for disease in patients without comorbidity(97%), while Omicron BA.2 caused disease primarily in those with comorbidity(77%). Tissue adaptation studies brought forth higher propensity of Omicron variants to bronchial tissue than lung, contrary to observation in Delta variants from Delhi. Study of codon usage pattern distinguished the prevalent variants, clustering them separately, Omicron BA.2 isolated in February grouped away from December strains, and all BA.2 after December acquired a new mutation S959P in ORF1b (44.3% of BA.2 in the study) indicating ongoing evolution. Loss of critical spike mutations in Omicron BA.2 and gain of immune evasion mutations including G142D, reported in Delta but absent in BA.1, and S371F instead of S371L in BA.1 could possibly be due to evolutionary trade-off and explain very brief period of BA.1 in December 2021, followed by complete replacement by BA.2.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.